GLP-1 Medication Insights: How Tirzepatide Enhances Fat Loss Effectively
Advanced Pharmacodynamics of Tirzepatide in Fat Metabolism Tirzepatide, a novel GLP-1 and GIP receptor agonist, represents an innovative frontier in injectable weight-loss therapies. Unlike traditional GLP-1 receptor agonists that primarily modulate appetite and glucose metabolism, tirzepatide’s dual agonism synergistically enhances insulin sensitivity and accelerates lipolysis, thereby promoting more efficient fat oxidation. This dual incretin effect … Read more